ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Payline In 1985 Likely To Be 170; $5.9 Million To Be Diverted to AIDS

December 7, 1984

More Workers Quit Smoking When Health Messages Combined

August 30, 2002

Managed Care: “Natural Alliance” Between Managed Care And Academic Centers, McGivney Says

January 24, 1997

NCI Shifts Money to Save 100 Training Slots

July 14, 1989

Million Dollar Awards Pace Contracts Rush

July 4, 1975

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014